OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Genetic predisposition similarities between NASH and ASH: Identification of new therapeutic targets
Cristiana Bianco, Elia Casirati, Francesco Malvestiti, et al.
JHEP Reports (2021) Vol. 3, Iss. 3, pp. 100284-100284
Open Access | Times Cited: 43
Cristiana Bianco, Elia Casirati, Francesco Malvestiti, et al.
JHEP Reports (2021) Vol. 3, Iss. 3, pp. 100284-100284
Open Access | Times Cited: 43
Showing 26-50 of 43 citing articles:
Role of NAFLD on the Health Related QoL Response to Lifestyle in Patients With Metabolic Syndrome: The PREDIMED Plus Cohort
Diego Martínez‐Urbistondo, Rodrigo San‐Cristobal, Paula Villares, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 11
Diego Martínez‐Urbistondo, Rodrigo San‐Cristobal, Paula Villares, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 11
The rs72613567:TA polymorphism in HSD17B13 is associated with survival benefit after development of hepatocellular carcinoma
Hamish Innes, Marsha Y. Morgan, Jochen Hampe, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 6, pp. 623-631
Open Access | Times Cited: 6
Hamish Innes, Marsha Y. Morgan, Jochen Hampe, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 6, pp. 623-631
Open Access | Times Cited: 6
The genetics of portal hypertension: Recent developments and the road ahead
Sarah Shalaby, Luisa Ronzoni, Virginia Hernández‐Gea, et al.
Liver International (2023) Vol. 43, Iss. 12, pp. 2592-2603
Open Access | Times Cited: 6
Sarah Shalaby, Luisa Ronzoni, Virginia Hernández‐Gea, et al.
Liver International (2023) Vol. 43, Iss. 12, pp. 2592-2603
Open Access | Times Cited: 6
Immunometabolic factors contributing to obesity-linked hepatocellular carcinoma
May G. Akl, Scott B. Widenmaier
Frontiers in Cell and Developmental Biology (2023) Vol. 10
Open Access | Times Cited: 4
May G. Akl, Scott B. Widenmaier
Frontiers in Cell and Developmental Biology (2023) Vol. 10
Open Access | Times Cited: 4
Alanine aminotransferase as a risk marker for new-onset metabolic dysfunction-associated fatty liver disease
Di Wang, Bing-Yan Zhou, Lei Xiang, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 25, pp. 3132-3139
Open Access | Times Cited: 1
Di Wang, Bing-Yan Zhou, Lei Xiang, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 25, pp. 3132-3139
Open Access | Times Cited: 1
Pantothenate Kinase 1 Inhibits the Progression of Hepatocellular Carcinoma by Negatively Regulating Wnt/β-catenin Signaling
Yu-Yuan Zi, Jie Gao, Chenglv Wang, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 4, pp. 1539-1554
Open Access | Times Cited: 7
Yu-Yuan Zi, Jie Gao, Chenglv Wang, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 4, pp. 1539-1554
Open Access | Times Cited: 7
Genetic predisposition to metabolic dysfunction-associated fatty liver disease
А.Е. Абатуров, Anna Nikulina
CHILD`S HEALTH (2024) Vol. 19, Iss. 3, pp. 162-174
Open Access | Times Cited: 1
А.Е. Абатуров, Anna Nikulina
CHILD`S HEALTH (2024) Vol. 19, Iss. 3, pp. 162-174
Open Access | Times Cited: 1
Liver specific thyroid hormone receptor-β agonism alleviates alcoholic steatohepatitis (ASH) in mice
Ambuj Shahi, Abhishek Yadav, Sangam Rajak, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 734, pp. 150742-150742
Closed Access | Times Cited: 1
Ambuj Shahi, Abhishek Yadav, Sangam Rajak, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 734, pp. 150742-150742
Closed Access | Times Cited: 1
The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile
Alana Aragón‐Herrera, Manuel Otero-Santiago, Laura Anido‐Varela, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
Alana Aragón‐Herrera, Manuel Otero-Santiago, Laura Anido‐Varela, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
MBOAT7 rs641738 Variant Is Not Associated with an Increased Risk of Hepatocellular Carcinoma in a Latin American Cohort
Spencer Goble, Joseph Akambase, Jhon Prieto, et al.
Digestive Diseases and Sciences (2023) Vol. 68, Iss. 11, pp. 4212-4220
Open Access | Times Cited: 3
Spencer Goble, Joseph Akambase, Jhon Prieto, et al.
Digestive Diseases and Sciences (2023) Vol. 68, Iss. 11, pp. 4212-4220
Open Access | Times Cited: 3
Liver specific, systemic and genetic contributors to alcohol-related liver disease progression
Bernd Schnabl, Gavin E. Arteel, Felix Stickel, et al.
Zeitschrift für Gastroenterologie (2022) Vol. 60, Iss. 01, pp. 36-44
Open Access | Times Cited: 4
Bernd Schnabl, Gavin E. Arteel, Felix Stickel, et al.
Zeitschrift für Gastroenterologie (2022) Vol. 60, Iss. 01, pp. 36-44
Open Access | Times Cited: 4
The clinically relevant MTARC1 p.Ala165Thr variant impacts neither the fold nor active site architecture of the human mARC1 protein
Michel A. Struwe, Bernd Clement, Axel J. Scheidig
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Michel A. Struwe, Bernd Clement, Axel J. Scheidig
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Fighting Fatty Liver Disease: Pathogenesis and Therapeutic Approaches
Athraa fouad kadhium
International Journal of Medical Science and Dental Health (2024) Vol. 10, Iss. 08, pp. 27-38
Open Access
Athraa fouad kadhium
International Journal of Medical Science and Dental Health (2024) Vol. 10, Iss. 08, pp. 27-38
Open Access
enHanCCing knowledge of genetic factors in primary liver tumor
Jill Koshiol, Marcin Krawczyk
Hepatology (2024) Vol. 80, Iss. 1, pp. 11-13
Open Access
Jill Koshiol, Marcin Krawczyk
Hepatology (2024) Vol. 80, Iss. 1, pp. 11-13
Open Access
Top level research in hepatology: COVID-19 and beyond
Sven Francque
JHEP Reports (2021) Vol. 3, Iss. 3, pp. 100302-100302
Open Access | Times Cited: 1
Sven Francque
JHEP Reports (2021) Vol. 3, Iss. 3, pp. 100302-100302
Open Access | Times Cited: 1
Machine learning-based hub gene identification of pyroptosis-related nonalcoholic fatty liver disease
Luping Yang, Shiyi Liu, Run Zhou, et al.
Research Square (Research Square) (2023)
Open Access
Luping Yang, Shiyi Liu, Run Zhou, et al.
Research Square (Research Square) (2023)
Open Access
The Genetics of Alcohol-Related Liver Disease
Hamish Innes, Felix Stickel
Springer eBooks (2023), pp. 975-996
Closed Access
Hamish Innes, Felix Stickel
Springer eBooks (2023), pp. 975-996
Closed Access
Joseph L. Dempsey, George N. Ioannou, Rotonya M. Carr
Seminars in Liver Disease (2023) Vol. 43, Iss. 04
Open Access
